Remove 2023 Remove Labelling Remove Packaging
article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent between the forecast period: 2023 and 2028. Having been valued at $27.04

Packaging 118
article thumbnail

Guidance for medicine packaging under Windsor Framework

European Pharmaceutical Review

The Windsor Framework, announced on 9 June 2023 by the Medicines and Healthcare products Regulatory Agency (MHRA), provides a long-term solution for the supply of medicines into Northern Ireland. The agreement stipulates that certain conditions must be met in the labelling and packaging of these medicinal products.

Packaging 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ampoules packaging market forecast to 2033

European Pharmaceutical Review

A report by The Brainy Insights has predicted that the ampoules packaging market will value $9.83 This is expected to be largely driven by increasing demand for this packaging type. Considering material type, glass ampoule packaging was found to hold a market share of around 77 percent in 2023, in comparison to plastic.

article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

A market report has identified that global demand for electronic smart packaging will reach $2.6 percent from 2023, according to the data. Smart packaging has potential for the integration of electronic functionality, enabling compliance, material identification, condition monitoring and asset tracking of pharmaceutical products.

article thumbnail

Five Interesting Things To Know About Sulopenem (Orlynvah)

IDStewardship

The package insert for sulopenem recommends taking it with food to maximize bioavailability. In case you are wondering, the FDA label does not list any hepatic dose adjustments. 2023 Jan 6;76(1):78-88. 2023 Jan 6;76(1):66-77. 2023 Sep 18;77(6):937. Orlynvah [package insert]. Clin Infect Dis. Dunne MW, et al.

Packaging 130
article thumbnail

FDA Issues Two Guidance Documents on Food Allergen Labeling Requirements

The FDA Law Blog

Food and Drug Administration (FDA) issued two guidance documents, one draft and one final, on food allergen labeling requirements. 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g.,

article thumbnail

Rising Demand for Pharmaceutical Secondary Packaging Providers

Roots Analysis

trillion in 2023. This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and Secondary Packaging solutions. . 3] Some of the advantages offered by pharmaceutical secondary packaging have been depicted below.